These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25941882)

  • 1. Pulmonary Delivery of Voriconazole Loaded Nanoparticles Providing a Prolonged Drug Level in Lungs: A Promise for Treating Fungal Infection.
    Das PJ; Paul P; Mukherjee B; Mazumder B; Mondal L; Baishya R; Debnath MC; Dey KS
    Mol Pharm; 2015 Aug; 12(8):2651-64. PubMed ID: 25941882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan-coated nanoparticles enhanced lung pharmacokinetic profile of voriconazole upon pulmonary delivery in mice.
    Paul P; Sengupta S; Mukherjee B; Shaw TK; Gaonkar RH; Debnath MC
    Nanomedicine (Lond); 2018 Mar; 13(5):501-520. PubMed ID: 29383985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly-lactide-co-glycolide nanoparticles containing voriconazole for pulmonary delivery: in vitro and in vivo study.
    Sinha B; Mukherjee B; Pattnaik G
    Nanomedicine; 2013 Jan; 9(1):94-104. PubMed ID: 22633899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
    Ohashi K; Kabasawa T; Ozeki T; Okada H
    J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nebulised surface-active hybrid nanoparticles of voriconazole for pulmonary Aspergillosis demonstrate clathrin-mediated cellular uptake, improved antifungal efficacy and lung retention.
    Kaur R; Dennison SR; Burrow AJ; Rudramurthy SM; Swami R; Gorki V; Katare OP; Kaushik A; Singh B; Singh KK
    J Nanobiotechnology; 2021 Jan; 19(1):19. PubMed ID: 33430888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and properties of inhalable nanocomposite particles for treatment of lung cancer.
    Tomoda K; Ohkoshi T; Hirota K; Sonavane GS; Nakajima T; Terada H; Komuro M; Kitazato K; Makino K
    Colloids Surf B Biointerfaces; 2009 Jul; 71(2):177-82. PubMed ID: 19264458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
    Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
    J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled sildenafil nanocomposites: lung accumulation and pulmonary pharmacokinetics
    Ghasemian E; Vatanara A; Rouini MR; Rouholamini Najafabadi A; Gilani K; Lavasani H; Mohajel N
    Pharm Dev Technol; 2016 Dec; 21(8):961-971. PubMed ID: 26428267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers.
    Ungaro F; d'Angelo I; Coletta C; d'Emmanuele di Villa Bianca R; Sorrentino R; Perfetto B; Tufano MA; Miro A; La Rotonda MI; Quaglia F
    J Control Release; 2012 Jan; 157(1):149-59. PubMed ID: 21864595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhalable microspheres embedding chitosan-coated PLGA nanoparticles for 2-methoxyestradiol.
    Guo X; Zhang X; Ye L; Zhang Y; Ding R; Hao Y; Zhao Y; Zhang Z; Zhang Y
    J Drug Target; 2014 Jun; 22(5):421-7. PubMed ID: 24417740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanosuspension as an Efficient Carrier for Improved Ocular Permeation of Voriconazole.
    Qin T; Dai Z; Xu X; Zhang Z; You X; Sun H; Liu M; Zhu H
    Curr Pharm Biotechnol; 2021; 22(2):245-253. PubMed ID: 32867650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose tolerability of chronically inhaled voriconazole solution in rodents.
    Tolman JA; Nelson NA; Bosselmann S; Peters JI; Coalson JJ; Wiederhold NP; Williams RO
    Int J Pharm; 2009 Sep; 379(1):25-31. PubMed ID: 19524030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nebulized voriconazole in infections with Scedosporium apiospermum--case report and review of the literature.
    Holle J; Leichsenring M; Meissner PE
    J Cyst Fibros; 2014 Jul; 13(4):400-2. PubMed ID: 24263169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation, optimization, and nephrotoxicity evaluation of an antifungal in situ nasal gel loaded with voriconazole‒clove oil transferosomal nanoparticles.
    Kammoun AK; Khedr A; Hegazy MA; Almalki AJ; Hosny KM; Abualsunun WA; Murshid SSA; Bakhaidar RB
    Drug Deliv; 2021 Dec; 28(1):2229-2240. PubMed ID: 34668818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of nanoparticle properties, detection method, delivery route and animal model on poly(lactic-co-glycolic) acid nanoparticles biodistribution in mice and rats.
    Simon LC; Sabliov CM
    Drug Metab Rev; 2014 May; 46(2):128-41. PubMed ID: 24303927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dry powder insufflation of crystalline and amorphous voriconazole formulations produced by thin film freezing to mice.
    Beinborn NA; Du J; Wiederhold NP; Smyth HD; Williams RO
    Eur J Pharm Biopharm; 2012 Aug; 81(3):600-8. PubMed ID: 22569473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voriconazole Concentrations in Plasma and Epithelial Lining Fluid after Inhalation and Oral Treatment.
    Andersen CU; Sønderskov LD; Bendstrup E; Voldby N; Cass L; Ayrton J; Hilberg O
    Basic Clin Pharmacol Toxicol; 2017 Nov; 121(5):430-434. PubMed ID: 28609608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voriconazole inhalation powder: A novel therapeutic alternative for invasive pulmonary fungal infections.
    Gardiner BJ; Ivulich SP; Snell GI
    Transpl Infect Dis; 2024 Jun; 26(3):e14264. PubMed ID: 38465782
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhanced properties of discrete pulmonary deoxyribonuclease I (DNaseI) loaded PLGA nanoparticles during encapsulation and activity determination.
    Osman R; Kan PL; Awad G; Mortada N; El-Shamy AE; Alpar O
    Int J Pharm; 2011 Apr; 408(1-2):257-65. PubMed ID: 21335080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.